tiprankstipranks
Trending News
More News >
Genmab A/S (GB:0MGB)
LSE:0MGB
Advertisement

Genmab A/S (0MGB) Stock Statistics & Valuation Metrics

Compare
10 Followers

Total Valuation

Genmab A/S has a market cap or net worth of kr85.31B. The enterprise value is kr64.38B.
Market Capkr85.31B
Enterprise Valuekr64.38B

Share Statistics

Genmab A/S has 64,154,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding64,154,250
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

Genmab A/S’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 14.13%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)14.13%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee8.16M
Profits Per Employee2.97M
Employee Count2,638
Asset Turnover0.47
Inventory Turnover15.89

Valuation Ratios

The current PE Ratio of Genmab A/S is 11.2. Genmab A/S’s PEG ratio is ―.
PE Ratio11.2
PS Ratio0.00
PB Ratio0.00
Price to Fair Value2.63
Price to FCF0.00
Price to Operating Cash Flow14.51
PEG Ratio

Income Statement

In the last 12 months, Genmab A/S had revenue of 21.53B and earned 7.84B in profits. Earnings per share was 122.21.
Revenue21.53B
Gross Profit20.54B
Operating Income6.70B
Pretax Income9.16B
Net Income7.84B
EBITDA7.39B
Earnings Per Share (EPS)122.21

Cash Flow

In the last 12 months, operating cash flow was 69.78M and capital expenditures -123.47M, giving a free cash flow of -53.70M billion.
Operating Cash Flow69.78M
Free Cash Flow-53.70M
Free Cash Flow per Share-0.84

Dividends & Yields

Genmab A/S pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.96
52-Week Price Change-26.41%
50-Day Moving Average1.40K
200-Day Moving Average1.44K
Relative Strength Index (RSI)45.39
Average Volume (3m)12.97K

Important Dates

Genmab A/S upcoming earnings date is Aug 7, 2025, Before Open (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date

Financial Position

Genmab A/S as a current ratio of 5.25, with Debt / Equity ratio of 2.70%
Current Ratio5.25
Quick Ratio5.24
Debt to Market Cap0.00
Net Debt to EBITDA-1.19
Interest Coverage Ratio55.86

Taxes

In the past 12 months, Genmab A/S has paid 1.32B in taxes.
Income Tax1.32B
Effective Tax Rate0.14

Enterprise Valuation

Genmab A/S EV to EBITDA ratio is 11.86, with an EV/FCF ratio of 11.56.
EV to Sales4.07
EV to EBITDA11.86
EV to Free Cash Flow11.56
EV to Operating Cash Flow11.28

Balance Sheet

Genmab A/S has kr3.23B in cash and marketable securities with kr143.00M in debt, giving a net cash position of -kr3.08B billion.
Cash & Marketable Securitieskr3.23B
Total Debtkr143.00M
Net Cash-kr3.08B
Net Cash Per Share-kr48.06
Tangible Book Value Per Sharekr337.58

Margins

Gross margin is 95.35%, with operating margin of 31.14%, and net profit margin of 36.44%.
Gross Margin95.35%
Operating Margin31.14%
Pretax Margin42.57%
Net Profit Margin36.44%
EBITDA Margin34.33%
EBIT Margin32.89%

Analyst Forecast

The average price target for Genmab A/S is kr1,988.43, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Targetkr1,988.43
Price Target Upside43.35% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis